Assessment efficacy of omega-3 on metabolic and inflammatory Indices in patients with schizophrenia taking clozapine and sodium valproate in Mashhad, Iran

Vice chancellor for research, Mashhad University of Medical Sciences0 个研究点目标入组 56 人开始时间: 待定最近更新: 2018年2月22日

适应症

试验速览

暂无简介。

•patients with schizophrenia admitted in Hejazi and Ibn Sina hospital in Mashhad that treated with clozapine and valproate at least 3 months (clozapine dose of 200 to 400 mg); Age 18 years or older; triglyceride levels in the morning between 200 to 499 Milligrams per deciliter; metabolic indices of patients before starting treatment with clozapine and valproate are normal. Exclusion criteria: Pregnancy or Lactation; history of sensitivity to fish oil; use of omega-3 in the past few months; Having obvious bleeding disorders or a history of using heparin and coumarin; The reluctance of patients participating in the study; use of other drugs such as statins; history of consumption or abuse of alcohol or drugs within 6 months from baseline.

发起方

Vice chancellor for research, Mashhad University of Medical Sciences